Small-Molecule Inhibition of Wee1 Kinase by MK-1775 Selectively Sensitizes P53-Deficient Tumor Cells to DNA-damaging Agents

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-0463
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

MK-1775, a Small Molecule Wee1 Inhibitor, Enhances Anti-Tumor Efficacy of Various DNA-damaging Agents, Including 5-Fluorouracil

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

Depletion of ATR Selectively Sensitizes ATM-deficient Human Mammary Epithelial Cells to Ionizing Radiation and DNA-damaging Agents

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2014English

Genetic Inhibition of the Atypical Kinase Wee1 Selectively Drives Apoptosis of P53 Inactive Tumor Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Multiple Defects Sensitize P53-Deficient Head and Neck Cancer Cells to the WEE1 Kinase Inhibition

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2005English

Selinexor Reduces the Expression of DNA Damage Repair Proteins and Sensitizes Cancer Cells to DNA Damaging Agents

Oncotarget
Oncology
2018English

Hyperactive End Joining Repair Mediates Resistance to DNA Damaging Therapy in P53-Deficient Cells

2020English

Sensitization of Cancer Cells to DNA Damaging Agents by Imidazolines

English

Small-Molecule Ferroptotic Agents With Potential to Selectively Target Cancer Stem Cells

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy